{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:24:25Z","timestamp":1793946265444,"version":"4.8.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001636","name":"University College Cork","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.rcsop.2026.100846","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:47:04Z","timestamp":1789832824000},"page":"100846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stakeholders' views of the implementation of pharmacist prescribing in the community pharmacy setting: a mixed-methods systematic review"],"prefix":"10.1016","volume":"24","author":[{"given":"Anna","family":"Colthorpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eimear","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2026.100846_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.rcsop.2026.100846_bb0010","series-title":"Health at a glance: Europe 2024: state of health in the EU cycle","author":"OECD","year":"2024"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/2042098616646726","article-title":"Nonmedical prescribing: where are we now?","volume":"7","author":"Cope","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"7","key":"10.1016\/j.rcsop.2026.100846_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214630","article-title":"Non-medical prescribing in the United Kingdom National Health Service: a systematic policy review","volume":"14","author":"Graham-Clarke","year":"2019","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/hsc.12746","article-title":"Independent prescribing in primary care: a survey of patients\u2019, prescribers\u2019 and colleagues\u2019 perceptions and experiences","volume":"27","author":"Hindi","year":"2019","journal-title":"Health Soc Care Community"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13827","article-title":"Pharmacist non-medical prescribing in primary care. A systematic review of views, opinions, and attitudes","volume":"75","author":"Mills","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pharmacy13060157","article-title":"Community pharmacist prescribing: roles and competencies\u2014a systematic review and implications","volume":"13","author":"Clemens","year":"2025","journal-title":"Pharmacy"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.sapharm.2018.06.001","article-title":"The role of pharmacists in general practice: a realist review","volume":"15","author":"Anderson","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.sapharm.2024.01.006","article-title":"The accessibility of pharmacist prescribing and impacts on medicines access: a systematic review","volume":"20","author":"Walpola","year":"2024","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"10.1016\/j.rcsop.2026.100846_bb0060","series-title":"In practice: guidance for pharmacist prescribers","author":"General Pharmaceutical Council","year":"2025"},{"key":"10.1016\/j.rcsop.2026.100846_bb0050","article-title":"Pharmacists as independent prescribers in community pharmacy: a scoping review","author":"Mesbahi","year":"2024","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0055","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jac5.1245","article-title":"Current status of prescriptive authority by pharmacists in the United States","volume":"3","author":"Sachdev","year":"2020","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102192","article-title":"The community pharmacist as an independent prescriber: a scoping review","volume":"64","author":"Piraux","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"8","key":"10.1016\/j.rcsop.2026.100846_bb0070","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.sapharm.2020.11.017","article-title":"Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from European countries","volume":"17","author":"Paudyal","year":"2020","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"10","key":"10.1016\/j.rcsop.2026.100846_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14424","article-title":"Community pharmacists\u2019 management of minor ailments in developing countries: a systematic review of types, recommendations, information gathering and counselling practices","volume":"75","author":"Yusuff","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.sapharm.2025.11.009","article-title":"Identifying outcomes for evaluating the impact of pharmacist prescribing: a rapid overview of reviews","volume":"22","author":"Ali","year":"2026","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007328","article-title":"Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation","volume":"5","author":"Todd","year":"2015","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.rcsop.2026.100846_bb0090","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bcp.13624","article-title":"Stakeholders\u2019 views and experiences of pharmacist prescribing: a systematic review","volume":"84","author":"Jebara","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/ijpp.12557","article-title":"Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences","volume":"27","author":"Zhou","year":"2019","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052227","article-title":"Barriers and facilitators to implementation of non-medical independent prescribing in primary care in the UK: a qualitative systematic review","volume":"12","author":"Edwards","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13012-015-0242-0","article-title":"Making sense of implementation theories, models and frameworks","volume":"10","author":"Nilsen","year":"2015","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13012-016-0437-z","article-title":"A systematic review of the use of the consolidated framework for implementation research","volume":"11","author":"Kirk","year":"2015","journal-title":"Implement Sci"},{"issue":"8","key":"10.1016\/j.rcsop.2026.100846_bb0120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.sapharm.2017.10.004","article-title":"Identification of the relationship between barriers and facilitators of pharmacist prescribing and self-reported prescribing activity using the theoretical domains framework","volume":"14","author":"Isenor","year":"2017","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sapharm.2016.01.002","article-title":"Pharmacist prescribing: a scoping review about the views and experiences of patients and the public","volume":"13","author":"Famiyeh","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2026.100846_bb0140","series-title":"JBI manual for evidence synthesis","article-title":"Mixed methods systematic reviews","author":"Lizarondo","year":"2024"},{"key":"10.1016\/j.rcsop.2026.100846_bib586","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.rcsop.2026.100846_bb0145","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.rcsop.2026.100846_bb0150","series-title":"Citationchaser: an R package and Shiny app for forward and backward citations chasing in academic searching","author":"Haddaway","year":"2021"},{"key":"10.1016\/j.rcsop.2026.100846_bb0155","author":"Veritas Health Innovation"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"Educ Inform"},{"key":"10.1016\/j.rcsop.2026.100846_bb0165","unstructured":"Noyes J, Booth A, Cargo M, Flemming K, Harden A, Harris J, Garside R, Hannes K, Pantoja T, Thomas J. Chapter 21: Qualitative Evidence [Last Updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, Editor(s). Cochrane handbook for systematic reviews of interventions version 6.5. Cochrane, 2024. Available from Cochrane.Org\/Handbook."},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.rcsop.2026.100846_bb0175","series-title":"NVivo (Version 15) [Computer Software]","author":"QSR International Pty Ltd","year":"2024"},{"key":"10.1016\/j.rcsop.2026.100846_bb0180","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5. Cochrane","article-title":"Chapter 3: defining the criteria for including studies and how they will be grouped for the synthesis","author":"McKenzie","year":"2024"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0185","first-page":"173","article-title":"Factors influencing the implementation of a new pharmacist prescribing service in community pharmacies","volume":"11","author":"Amador-Fern\u00e1ndez","year":"2023","journal-title":"Pharm Basel Switz"},{"issue":"NA","key":"10.1016\/j.rcsop.2026.100846_bb0190","article-title":"Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments","volume":"14","author":"Amador-Fern\u00e1ndez","year":"2024","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0195","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/ijpp.12498","article-title":"Exploring views of pharmacists on antibacterial prescribing: a Maltese perspective","volume":"27","author":"Attard Pizzuto","year":"2019","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jphs.12067","article-title":"Patients\u2019 views on their consultation experience in community pharmacies and the potential prescribing role for pharmacists in Nigeria","volume":"5","author":"Auta","year":"2014","journal-title":"J Pharm Health Serv Res"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0205","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s11096-016-0321-6","article-title":"Stakeholders\u2019 views on granting prescribing authority to pharmacists in Nigeria: a qualitative study","volume":"38","author":"Auta","year":"2016","journal-title":"Int J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.japh.2023.08.005","article-title":"Pharmacist furnishing of hormonal contraception in California\u2019s Central Valley","volume":"64","author":"Azad","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.japh.2022.10.028","article-title":"An observational study of the extent of naloxone furnishing in California Central Valley community pharmacies","volume":"63","author":"Banawis","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0220","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2025.2456382","article-title":"Pharmacist prescriber in Italy and possible changes to current legislation: survey of attitudes among pharmacists, family doctors and users","volume":"18","author":"Baratta","year":"2025","journal-title":"J Pharm Policy Pract"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1715163518781175","article-title":"Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community","volume":"151","author":"Beahm","year":"2018","journal-title":"Can Pharm J CPJ Rev Pharm Can RPC"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/17151635231152218","article-title":"Community pharmacists\u2019 acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)","volume":"156","author":"Booker","year":"2023","journal-title":"Can Pharm J"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4314\/rjmhs.v7i2.1","article-title":"Barriers to community pharmacists\u2019 prescribing role in Limpopo Province, South Africa: a qualitative study","volume":"7","author":"Brilliant Moloto","year":"2024","journal-title":"Rwanda J Med Health Sci"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0240","article-title":"Implementation of pharmacist-prescribed contraceptive services: a case series of early adopters","volume":"1","author":"Campi","year":"2024","journal-title":"JAPhA Pr Innov"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0245","first-page":"1","article-title":"Exploring community pharmacists\u2019 perceptions towards the prescribing role in Limpopo province, South Africa: a qualitative study","volume":"11","author":"Chuene","year":"2024","journal-title":"Int Arch Health Sci"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0250","doi-asserted-by":"crossref","first-page":"E246018","DOI":"10.1001\/jamanetworkopen.2024.6018","article-title":"Willingness of pharmacists to prescribe medication abortion in California","volume":"7","author":"Cohen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0255","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v15i3.6230","article-title":"Community-based pharmacists\u2019 perspectives on prescribing authority for the minor ailments and contraception service in British Columbia","volume":"15","author":"Dahri","year":"2024","journal-title":"Innov Pharm"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.japh.2023.10.025","article-title":"Implementation of pharmacy access to hormonal contraception","volume":"64","author":"Dale","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.sapharm.2018.07.016","article-title":"Exploring pharmacy service users\u2019 support for and willingness to use community pharmacist prescribing services","volume":"15","author":"Famiyeh","year":"2019","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0270","first-page":"1","article-title":"Family physicians\u2019 perceptions of pharmacists prescribing in Alberta","volume":"34","author":"Faruquee","year":"2019","journal-title":"J Interprof Care"},{"issue":"18","key":"10.1016\/j.rcsop.2026.100846_bb0275","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2146\/ajhp150691","article-title":"Qualitative interviews regarding pharmacist prescribing in the community setting","volume":"73","author":"Feehan","year":"2016","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11096-006-9018-6","article-title":"Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists","volume":"28","author":"George","year":"2006","journal-title":"Pharm World Sci"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1211\/ijpp.15.1.0005","article-title":"Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers","volume":"15","author":"George","year":"2007","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/03630242.2019.1635561","article-title":"Facilitators and barriers to implementing pharmacist-prescribed hormonal contraception in California independent pharmacies","volume":"60","author":"Gomez","year":"2020","journal-title":"Women Health"},{"key":"10.1016\/j.rcsop.2026.100846_bb0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2022.05.013","article-title":"Community perspectives on pharmacist-prescribed hormonal contraception in rural California","volume":"114","author":"Gomez","year":"2022","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0300","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sapharm.2022.08.014","article-title":"Increased self-reported pharmacist prescribing during the COVID-19 pandemic: using the Theoretical Domains Framework to identify barriers and facilitators to prescribing","volume":"19","author":"Grant","year":"2023","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/17151635241280724","article-title":"Enabling pharmacist prescribing: lessons learned in Nova Scotia using behaviour change theory","volume":"158","author":"Grant","year":"2025","journal-title":"Can Pharm J"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0310","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jcpt.12165","article-title":"How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration","volume":"39","author":"Guirguis","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1071\/HC13223","article-title":"General practitioners\u2019 views of pharmacists\u2019 current and potential contributions to medication review and prescribing in New Zealand","volume":"5","author":"Hatah","year":"2013","journal-title":"J Prim Health Care"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0320","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.japh.2020.02.026","article-title":"Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists","volume":"60","author":"Herman","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.2042-7174.2010.00077.x","article-title":"Pharmacy clients\u2019 attitudes to expanded pharmacist prescribing and the role of agency theory on involved stakeholders","volume":"19","author":"Hoti","year":"2011","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0330","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11096-013-9766-z","article-title":"Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists","volume":"35","author":"Hoti","year":"2013","journal-title":"Int J Clin Pharmacol"},{"issue":"493","key":"10.1016\/j.rcsop.2026.100846_bb0335","first-page":"600","article-title":"Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment","volume":"53","author":"Hughes","year":"2003","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.rcsop.2026.100846_bb0340","series-title":"What prescribing means to pharmacists: a qualitative exploration of practising pharmacists in Alberta","first-page":"283","volume":"vol 22","author":"Hughes","year":"2014"},{"issue":"11","key":"10.1016\/j.rcsop.2026.100846_bb0345","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad549","article-title":"Opportunities to increase access to HIV prevention: evaluating the implementation of pharmacist-initiated pre-exposure prophylaxis in California","volume":"10","author":"Hunter","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0350","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.sapharm.2018.08.003","article-title":"Public perception of pharmacist-prescribed self-administered non-emergency hormonal contraception: an analysis of online social discourse","volume":"15","author":"Irwin","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0355","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s11096-024-01733-x","article-title":"Investigating practice integration of independent prescribing by community pharmacists using normalization process theory: a cross-sectional survey","volume":"46","author":"Karim","year":"2024","journal-title":"Int J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0360","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.japh.2020.06.005","article-title":"Attitudes about community pharmacy access to HIV prevention medications in California","volume":"60","author":"Koester","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102259","article-title":"Assessing student and patient perspectives on pharmacist-prescribed hormonal contraceptives","volume":"65","author":"Lemay","year":"2025","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy9020092","article-title":"Perceptions of independent pharmacist prescribing among health authority-and community-based pharmacists in northern British Columbia","volume":"9","author":"Lewis","year":"2021","journal-title":"Pharmacy"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0375","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.japh.2018.05.005","article-title":"Pharmacists\u2019 comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy","volume":"58","author":"Lio","year":"2018","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0380","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1211\/ijpp.15.1.0006","article-title":"Pharmacists\u2019 and mentors\u2019 views on the introduction of pharmacist supplementary prescribing: a qualitative evaluation of views and context","volume":"15","author":"Lloyd","year":"2007","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0385","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.japh.2020.09.020","article-title":"Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: a survey of patients receiving antiretroviral therapy","volume":"61","author":"Lutz","year":"2021","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2026.100846_bb0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1748-5908-8-109","article-title":"Factors influencing pharmacists\u2019 adoption of prescribing: qualitative application of the diffusion of innovations theory","volume":"8","author":"Makowsky","year":"2013","journal-title":"Implement Sci"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0395","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ijpp.12128","article-title":"Evaluating pharmacist prescribing for minor ailments","volume":"23","author":"Mansell","year":"2015","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2026.100846_bb0400","first-page":"11","article-title":"Community pharmacists\u2019 views on the early stages of implementation of a national pilot independent prescribing service in wales: a qualitative study","volume":"12","author":"Mantzourani","year":"2023","journal-title":"Integr Pharm Res Pract"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0405","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jac5.1169","article-title":"Women\u2019s perceptions of pharmacist-prescribed hormonal contraception","volume":"3","author":"Meredith","year":"2020","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0410","doi-asserted-by":"crossref","first-page":"677","DOI":"10.13005\/bpj\/2407","article-title":"Attitudes of community pharmacists towards expanding their prescribing role: a cross-sectional study","volume":"15","author":"Mhailan","year":"2022","journal-title":"Biomed Pharmacol J"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19031648","article-title":"Extended prescribing roles for pharmacists in Poland-a survey study","volume":"19","author":"Miszewska","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0420","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.contraception.2019.08.012","article-title":"Exploring emergency contraception prescribing by pharmacists in California","volume":"100","author":"Mody","year":"2019","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/ijpp.12084","article-title":"Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland","volume":"22","author":"Moore","year":"2014","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0430","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.japh.2020.11.020","article-title":"Student pharmacists\u2019 perceptions regarding pharmacist-prescribed hormonal contraceptives and their professional responsibility","volume":"61","author":"Mospan","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2015.03.013","article-title":"The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study","volume":"92","author":"Norman","year":"2015","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy8020099","article-title":"Attitudes of Michigan female college students about pharmacists prescribing birth control in a community pharmacy","volume":"8","author":"O\u2019Connell","year":"2020","journal-title":"Pharmacy"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy9040185","article-title":"Evaluation of student pharmacists\u2019 attitudes and perceptions of hormonal contraception prescribing in Indiana","volume":"9","author":"Papineau","year":"2021","journal-title":"Pharmacy"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0450","article-title":"Birth control use and access including pharmacist-prescribed contraception services during COVID-19","volume":"10","author":"Pelaccio","year":"2022","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.rcsop.2026.100846_bb0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6904-11-6","article-title":"The future of pharmaceutical care in France: a survey of final-year pharmacy students\u2019 opinions","volume":"11","author":"Perraudin","year":"2011","journal-title":"BMC Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0460","article-title":"Pharmacist outlooks on prescribing hormonal contraception following statewide scope of practice expansion","volume":"7","author":"Rafie","year":"2019","journal-title":"Pharmacy (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0465","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.japh.2021.11.002","article-title":"Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies","volume":"62","author":"Rafie","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0470","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jac5.1558","article-title":"Barriers and facilitators for pharmacists prescribing emergency contraception under statewide protocol","volume":"5","author":"Rafie","year":"2022","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0475","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40258-020-00615-3","article-title":"Identifying community pharmacist preferences for prescribing services in primary care in New Zealand: a discrete choice experiment","volume":"19","author":"Raghunandan","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"issue":"12","key":"10.1016\/j.rcsop.2026.100846_bb0480","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jac5.1730","article-title":"Implementation science to analyze motivators and barriers to pharmacist-prescribed contraception in Michigan community pharmacies","volume":"5","author":"Rashid","year":"2022","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100846_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy8030145","article-title":"Community pharmacists\u2019 motivation and barriers to providing and billing patient care services","volume":"8","author":"Reyes","year":"2020","journal-title":"Pharmacy"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0490","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/17151635241264517","article-title":"Community pharmacists\u2019 comfort levels with and barriers to application of an expanded scope of practice in Qu\u00e9bec","volume":"157","author":"Rouleau","year":"2024","journal-title":"Can Pharm J"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0495","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jphsr\/rmac042","article-title":"Community pharmacists\u2019 perception and attitudes toward independent prescribing in the United Arab Emirates: an exploratory study","volume":"13","author":"Sadeq","year":"2022","journal-title":"J Pharm Health Serv Res"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0500","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1715163517743269","article-title":"Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation","volume":"151","author":"Sandhu","year":"2018","journal-title":"Can Pharm J"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100846_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmacy8040191","article-title":"Role of pharmacists in hormonal contraceptive access: a survey of North Carolina pharmacists","volume":"8","author":"Seamon","year":"2020","journal-title":"Pharmacy"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0510","article-title":"A survey of the views and capabilities of community pharmacists in Western Australia regarding the rescheduling of selected oral antibiotics in a framework of pharmacist prescribing","author":"Sinkala","year":"2018","journal-title":"PeerJ"},{"issue":"6843","key":"10.1016\/j.rcsop.2026.100846_bb0515","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/bmj.304.6843.1670","article-title":"Pharmacy beyond the dispensary: general practitioners\u2019 views","volume":"304","author":"Spencer","year":"1992","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0520","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1345\/aph.1L609","article-title":"Cross sectional survey of the Scottish general public\u2019s awareness of, views on, and attitudes toward nonmedical prescribing","volume":"43","author":"Stewart","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0525","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S1463423617000925","article-title":"Building capacity in primary care: the implementation of a novel \u201cPharmacy First\u201d scheme for the management of UTI, impetigo and COPD exacerbation","volume":"19","author":"Stewart","year":"2018","journal-title":"Prim Health Care Res Dev"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100846_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy12050156","article-title":"Pharmacist-prescribed hormonal contraception: a survey of perceptions of Georgia community pharmacists and non-community pharmacists","volume":"12","author":"Stone","year":"2024","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0535","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3855\/jidc.9630","article-title":"Perceptions towards the prescribing of antibiotics by pharmacists and the use of antibiotics in primary care in South Africa","volume":"12","author":"Truter","year":"2018","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0540","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11096-016-0396-0","article-title":"Assessing pharmacists\u2019 readiness to prescribe oral antibiotics for limited infections using a case-vignette technique","volume":"39","author":"Ung","year":"2017","journal-title":"Int J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100846_bb0545","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/j.2055-2335.2008.tb00811.x","article-title":"Australian general practitioners\u2019 views on pharmacist prescribing","volume":"38","author":"Vracar","year":"2008","journal-title":"J Pharm Pract Res"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100846_bb0550","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0897190017737897","article-title":"Pharmacist intentions to prescribe hormonal contraception following new legislative authority in California","volume":"32","author":"Vu","year":"2019","journal-title":"J Pharm Pract"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0555","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.japh.2018.06.016","article-title":"Perceived preparedness for full-scope pharmacist services among recent Doctor of Pharmacy graduates from Ontario schools of pharmacy","volume":"58","author":"Waite","year":"2018","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2026.100846_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2024.105223","article-title":"Key stakeholder\u2019s attitudes towards the professional accountabilities and responsibilities of newly qualified Pharmacist Independent Prescribers (IPs) in England and enablers to implementation at scale?","volume":"152","author":"Warner","year":"2025","journal-title":"Health Policy"},{"key":"10.1016\/j.rcsop.2026.100846_bb0565","first-page":"14","article-title":"Community pharmacist perception of supplementary prescribing","volume":"1","author":"Wirth","year":"2011","journal-title":"J EuroMed Pharm"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100846_bb0570","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.japh.2020.03.013","article-title":"Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention","volume":"60","author":"Zhu","year":"2020","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2026.100846_bb0575","author":"International Pharmaceutical Federation (FIP)"},{"key":"10.1016\/j.rcsop.2026.100846_bb0580","author":"Department of Health"},{"key":"10.1016\/j.rcsop.2026.100846_bb0585","author":"NHS England"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:25:20Z","timestamp":1793942720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276626001447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":117,"alternative-id":["S2667276626001447"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100846","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stakeholders' views of the implementation of pharmacist prescribing in the community pharmacy setting: a mixed-methods systematic review","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100846"}}